Spironolactone Dosing for Hirsutism
For treating hirsutism, start spironolactone at 100 mg daily, with the option to increase to 200 mg daily if needed, given in divided doses (twice daily). 1
Recommended Dosing Regimen
The Endocrine Society Clinical Practice Guidelines explicitly recommend 100-200 mg/day of spironolactone, administered in divided doses (twice daily) for hirsutism treatment 1. This represents the evidence-based standard:
- Starting dose: 100 mg/day
- Maximum dose: 200 mg/day
- Administration: Split into twice-daily dosing to maintain steady drug levels
- Duration: At least 6-12 months before assessing full efficacy 1
Evidence Supporting This Dose Range
The 100-200 mg daily range is supported by multiple lines of evidence:
- Comparative efficacy: Spironolactone 100 mg/day demonstrates equivalent efficacy to finasteride 5 mg/day and flutamide 250-750 mg/day in randomized trials 1
- Meta-analysis data: Antiandrogens including spironolactone significantly reduced hirsutism scores compared to placebo (mean difference: -3.9; 95% CI: -5.4 to -2.3) 1
- Long-term studies: 200 mg/day as monotherapy for 12 months effectively reduced hirsutism in both idiopathic hirsutism and PCOS patients 2
Clinical Context and Nuances
For female pattern hair loss (a related but distinct indication), the same guideline notes that doses of 100-200 mg/day with prolonged treatment (at least 12 months) are needed, with hair regrowth or stabilization observed in 44-74% of patients 3. Patients with concurrent hirsutism or acne respond significantly better 3.
Lower doses (50 mg/day) have been studied but show less consistent results. One meta-analysis found no significant difference between 50 mg spironolactone and metformin for hirsutism reduction 4, suggesting this dose may be suboptimal.
Higher efficacy in specific populations: Spironolactone appears more effective in idiopathic hirsutism compared to PCOS-related hirsutism. In one study, spironolactone 200 mg/day reduced hirsutism scores equally to cyproterone acetate in idiopathic hirsutism, but was less effective in PCOS patients 2.
Important Clinical Considerations
Timeline expectations: Set realistic expectations with patients—pharmacological therapy requires at least 6 months before making dose adjustments or changing medications 1. The maximal effect may take 12-24 months.
Combination therapy: While spironolactone can be used as monotherapy, combining it with oral contraceptives may provide additional benefit, particularly in PCOS patients who need menstrual regulation and additional androgen suppression 5, 2.
Monitoring: The FDA label does not specify dermatologic indications (spironolactone is approved for heart failure, hypertension, edema, and hyperaldosteronism) 6, so this represents off-label use. However, the safety profile at 100-200 mg/day is well-established, with main side effects being menstrual irregularities, mild nausea, and polyuria 4, 7.
Common Pitfalls to Avoid
- Underdosing: Starting at 25-50 mg/day (doses used for heart failure or hypertension) will likely be ineffective for hirsutism
- Premature discontinuation: Stopping before 6 months due to perceived lack of efficacy—hair growth cycles require extended treatment
- Pregnancy risk: Spironolactone is contraindicated in pregnancy due to potential feminization of male fetuses; ensure effective contraception 8
- Inadequate patient counseling: Patients must understand this treats new hair growth but doesn't remove existing hair—cosmetic hair removal methods remain necessary initially